Gene · 1285
Papers2,040
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,040
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic reprogramming with stem cells regenerates glomerular epithelial podocytes in Alport syndrome. | Life Sci Alliance | 2024 | 38561223 | PubTator, text mining | PubMed |
| Trigenic COL4A3/COL4A4/COL4A5 Pathogenic Variants in Alport Syndrome: A Case Report. | Nephron | 2024 | 38547857 | PubTator, text mining | PubMed |
| Introducing Exome Sequencing as Part of the Diagnostic Algorithm for Pediatric Nephrology Patients in Bulgaria: A Single-Center Experience. | Nephron | 2024 | 38547852 | PubTator, text mining | PubMed |
| Ribonucleic Acid Sequencing Reveals the Upregulation and Resolution of Inflammation and Extracellular Matrix Remodeling in Lidocaine-Treated Human Acute Monocytic Leukemia Cell Line THP-1. | Biomedicines | 2024 | 38540122 | PubTator, text mining | PubMed |
| Alport syndrome and Alport kidney diseases - elucidating the disease spectrum. | Curr Opin Nephrol Hypertens | 2024 | 38477333 | PubTator, text mining | PubMed |
| Genetic diagnosis of Alport syndrome in 16 Chinese families. | Mol Genet Genomic Med | 2024 | 38433557 | PubTator, text mining | PubMed |
| A Deeper Insight into COL4A3, COL4A4, and COL4A5 Variants and Genotype-Phenotype Correlation of a Turkish Cohort with Alport Syndrome. | Mol Syndromol | 2024 | 38357258 | PubTator, text mining | PubMed |
| Increased prevalence of kidney cysts in individuals carrying heterozygous COL4A3 or COL4A4 pathogenic variants. | Nephrol Dial Transplant | 2024 | 38317457 | PubTator, text mining | PubMed |
| Evaluation of penalized and machine learning methods for asthma disease prediction in the Korean Genome and Epidemiology Study (KoGES). | BMC Bioinformatics | 2024 | 38308205 | PubTator, text mining | PubMed |
| Upregulated microRNA-125b-5p in patients with asthma-COPD overlap mediates oxidative stress and late apoptosis via targeting IL6R/TRIAP1 signaling. | Respir Res | 2024 | 38302925 | PubTator, text mining | PubMed |
| New insights from the genetic work-up in early onset nephrotic syndrome: report from a registry in western India. | Pediatr Nephrol | 2024 | 38294522 | PubTator, text mining | PubMed |
| Predicting Alu exonization in the human genome with a deep learning model. | bioRxiv | 2024 | 38260329 | PubTator, text mining | PubMed |
| Modulation of Extracellular Matrix Composition and Chronic Inflammation with Pirfenidone Promotes Scar Reduction in Retinal Wound Repair. | Cells | 2024 | 38247855 | PubTator, text mining | PubMed |
| Neutrophil-mediated type IV collagen degradation is elevated in patients with mild endoscopic ulcerative colitis reflecting early mucosal destruction. | Sci Rep | 2024 | 38238446 | PubTator, text mining | PubMed |
| Circulating Podocalyxin, Tumstatin/Col-IVα3 and Chitinase 1: New Culprits in Vitiligo Occurrence. | Dermatol Pract Concept | 2024 | 38236996 | PubTator, text mining | PubMed |
| Is there a dominant-negative effect in individuals with heterozygous disease-causing variants in COL4A3/COL4A4? | Clin Genet | 2024 | 38214412 | PubTator, text mining | PubMed |
| ANGPTL4 accelerates ovarian serous cystadenocarcinoma carcinogenesis and angiogenesis in the tumor microenvironment by activating the JAK2/STAT3 pathway and interacting with ESM1. | J Transl Med | 2024 | 38212795 | PubTator, text mining | PubMed |
| Frail inner limiting membrane maculopathy suggested to describe a new retinal Alport-like condition with two variants in three generations of females. | Ophthalmic Genet | 2024 | 38197426 | PubTator, text mining | PubMed |
| RNA-seq unravels distinct expression profiles of keloids and Dupuytren's disease. | Heliyon | 2024 | 38187218 | PubTator, text mining | PubMed |
| Replacing a kidney biopsy by exome sequencing in undetermined kidney diseases-not yet ready for prime time! | Clin Kidney J | 2024 | 38186890 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1285/papers?page=10